BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 29480189)

  • 1. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
    Sapkota S; Bäckman L; Dixon RA
    Neurobiol Aging; 2017 Apr; 52():81-89. PubMed ID: 28131014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.
    Thibeau S; McFall GP; Camicioli R; Dixon RA
    J Alzheimers Dis; 2017; 60(1):69-86. PubMed ID: 28800331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
    J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.
    Sweet RA; Seltman H; Emanuel JE; Lopez OL; Becker JT; Bis JC; Weamer EA; DeMichele-Sweet MA; Kuller LH
    Am J Psychiatry; 2012 Sep; 169(9):954-62. PubMed ID: 22952074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented Aging.
    Sapkota S; McFall GP; Masellis M; Dixon RA
    Front Aging Neurosci; 2021; 13():621023. PubMed ID: 34603005
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    Sapkota S; McFall GP; Masellis M; Dixon RA; Black SE
    J Alzheimers Dis; 2022; 85(2):545-560. PubMed ID: 34864669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
    Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.
    Santos-Rebouças CB; Gonçalves AP; Dos Santos JM; Abdala BB; Motta LB; Laks J; de Borges MB; de Rosso ALZ; Pereira JS; Nicaretta DH; Pimentel MMG
    Neuromolecular Med; 2017 Sep; 19(2-3):293-299. PubMed ID: 28567584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    Blujus JK; Korthauer LE; Awe E; Frahmand M; Driscoll I
    J Alzheimers Dis; 2020; 78(1):309-320. PubMed ID: 32986668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.
    Jun G; Naj AC; Beecham GW; Wang LS; Buros J; Gallins PJ; Buxbaum JD; Ertekin-Taner N; Fallin MD; Friedland R; Inzelberg R; Kramer P; Rogaeva E; St George-Hyslop P; ; Cantwell LB; Dombroski BA; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Lunetta KL; Martin ER; Montine TJ; Goate AM; Blacker D; Tsuang DW; Beekly D; Cupples LA; Hakonarson H; Kukull W; Foroud TM; Haines J; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD
    Arch Neurol; 2010 Dec; 67(12):1473-84. PubMed ID: 20697030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CLU and PICALM polymorphisms on AD risk: A study from south India.
    Shankarappa BM; Kota LN; Purushottam M; Nagpal K; Mukherjee O; Viswanath B; Varghese M; Bharath S; Jain S
    Asian J Psychiatr; 2017 Jun; 27():7-11. PubMed ID: 28558900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    Liu YB; Wang XJ; Tan L; Tan CC; Xu W;
    J Alzheimers Dis; 2023; 96(4):1651-1661. PubMed ID: 38007652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
    Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
    Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Genetic Risk Intensifies Neurocognitive Slowing Associated with Diabetes in Non-Demented Older Adults.
    McFall GP; Wiebe SA; Vergote D; Anstey KJ; Dixon RA
    Alzheimers Dement (Amst); 2015 Dec; 1(4):395-402. PubMed ID: 26665159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.
    Seripa D; Panza F; Paroni G; D'Onofrio G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Solfrizzi V; Bizzarro A; Boccardi V; Piccininni C; Daniele A; Logroscino G; Mecocci P; Masullo C; Greco A
    Mol Neurobiol; 2018 May; 55(5):4333-4344. PubMed ID: 28631188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.